In Vitro & In Vivo Diagnostic Substances
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 49.2K | -- | 1.66% | +33.9K | 2026-06-30 |
| BlackRock, Inc. | 34.7K | -- | 1.17% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 26.2K | -- | 0.89% | -5.9K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 20.2K | -- | 0.68% | -- | 2026-06-30 |
| CITADEL ADVISORS LLC | 19.1K | -- | 0.64% | +8.2K | 2026-06-30 |
| XTX Topco Ltd | 16.1K | -- | 0.54% | -- | 2026-06-30 |
| JANE STREET GROUP, LLC | 11.9K | -- | 0.40% | -69.3K | 2026-06-30 |
| STATE STREET CORP | 10.1K | -- | 0.34% | -- | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 2.8K | -- | 0.10% | -1.1K | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 1.8K | -- | 0.06% | -383 | 2026-06-30 |
